Overview

Study of Enteric-coated Mycophenolate Sodium Maintenance Therapy in Patients With Renal Transplant Receiving Cyclosporine Microemulsion and Steroids,

Status:
Completed

Trial end date:
2005-01-01

Target enrollment:

Participant gender:

Summary

The aim of this study is to evaluate if the addition of EC-MPS to CsA-ME allows the safe withdrawal of the concomitant corticosteroid therapy in long-term maintenance renal allograft recipients. All patients of the core study who are interested of being treated with EC-MPS will be included in an open-label extension study to collect further information on the long-term safety, tolerability and efficacy of this drug.

Phase:

Phase 3

Details

Lead Sponsor:

Novartis

Treatments:

Cyclosporine
Cyclosporins
Mycophenolate mofetil
Mycophenolic Acid